AUA2025: Chemotherapy and Immunotherapy for Urologists and Advanced Practice Providers (APPs)
AUAUniversity30 Heinä 2025

AUA2025: Chemotherapy and Immunotherapy for Urologists and Advanced Practice Providers (APPs)

AUA2025: Chemotherapy and Immunotherapy for Urologists and Advanced Practice Providers (APPs) CME Available: https://auau.auanet.org/node/43009 At the conclusion of this activity, participants will be able to: 1. Identify the guidelines for first-line and beyond treatment of patients with hormone-sensitive advanced and metastatic prostate cancer, including medications, their mechanism, side effects and efficacy. 2. Summarize the recommendations for first-line and beyond treatment of castrate-resistant metastatic and nonmetastatic prostate cancer, including medications, their mechanism, side effects and efficacy. 3. Diagram the treatment options for high-risk non-muscle invasive bladder cancer. 4. Distinguish the guideline-defined therapeutic options for locally advanced and metastatic bladder cancer. 5. Discuss treatment options for locally advanced and metastatic kidney cancer, including medications, their mechanism, side effects and efficacy. ACKNOWLEDGEMENTS: This educational activity is supported by independent educational grants from: Astellas, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Lantheus Medical Imaging, Novartis Pharmaceuticals Corporation, Pfizer, Inc.

Jaksot(421)

AUA2018 Take Home Messages Pediatrics plus Highlights From SPU and Journal of Urology

AUA2018 Take Home Messages Pediatrics plus Highlights From SPU and Journal of Urology

Take Home Messages from AUA2018 in Pediatrics presented by Emilie Johnson, MD, MPH. In addition Plenary Next Frontier presentations in the area of pediatric urology Highlights: Society for Pediatr...

6 Joulu 201823min

Use of Novel Hormonal Agents and Systemic Therapy in Advanced Prostate Cancer Highlights (2018)

Use of Novel Hormonal Agents and Systemic Therapy in Advanced Prostate Cancer Highlights (2018)

This podcast was developed from content delivered during the Use of Novel Hormonal Agents and Systemic Therapy in Advanced Prostate Cancer live course. Topics covered include: Practical Guide to an...

30 Marras 20181h 36min

Immuno-Oncology: A Focus on Prostate Cancer

Immuno-Oncology: A Focus on Prostate Cancer

Immuno-Oncology: A Focus on Prostate Cancer is the fourth webcast in the 4-part series. Topics will include "review of treatment options for advanced disease", "evolution of AR-directed treatment and ...

25 Marras 20181h 6min

AUA2018 Residents Forum - The Evolving Practice Of Urology

AUA2018 Residents Forum - The Evolving Practice Of Urology

AUA2018 Residents Forum - The Evolving Practice Of Urology by American Urological Association

15 Marras 201838min

AUA2018 Residents Forum - Wellness Burnout And Sustaining Your Career

AUA2018 Residents Forum - Wellness Burnout And Sustaining Your Career

AUA2018 Residents Forum - Wellness Burnout And Sustaining Your Career by American Urological Association

13 Marras 201843min

Immuno-Oncology: A Focus on Kidney Cancer

Immuno-Oncology: A Focus on Kidney Cancer

Immuno-Oncology: A Focus on Kidney Cancer is the third in the 4-part series. Topics will include "Review of Treatment Options for Systemic Disease", "Cytoeduction Debate" and "Impact of Immunotherapy ...

8 Marras 201847min

Sequencing of Chemotherapy and Immunotherapy in Advanced Prostate Cancer Present and Future (2018)

Sequencing of Chemotherapy and Immunotherapy in Advanced Prostate Cancer Present and Future (2018)

Sequencing of Chemotherapy and Immunotherapy in Advanced Prostate Cancer: Present and Future is the fourth and final in a 4-part series. Topics will include "Role of Chemotherapy and Performance Sta...

1 Marras 201844min

Incorporating New IO Therapies - How to Properly Administer IO Therapies in an Infusion Suite

Incorporating New IO Therapies - How to Properly Administer IO Therapies in an Infusion Suite

To improve clinicians’ understanding of current immunotherapeutic agents for the treatment of genitourinary (GU) cancer and to increase their ability to improve patient outcomes and the management of ...

29 Loka 201837min

Suosittua kategoriassa Koulutus

rss-murhan-anatomia
voi-hyvin-meditaatiot-2
psykopodiaa-podcast
rss-narsisti
adhd-podi
rss-liian-kuuma-peruna
rss-valo-minussa-2
aamukahvilla
jari-sarasvuo-podcast
rss-uskonto-on-tylsaa
rss-duodecim-lehti
rss-luonnollinen-synnytys-podcast
rss-arkea-ja-aurinkoa-podcast-espanjasta
rss-niinku-asia-on
kesken
salainen-paivakirja
psykologia
ihminen-tavattavissa-tommy-hellsten-instituutti
leveli
rss-tietoinen-yhteys-podcast-2